GlucAffect Blood Sugar Management Formula Earns Patent

In an eight-week, placebo-controlled clinical study of 50 overweight individuals with elevated blood glucose levels, test subjects taking GlucAffect lowered their fasting blood glucose by an average of 30%

Read more

Posted in Glucose & Insulin Medical Research